De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Astrana Health Beheer
Beheer criteriumcontroles 2/4
De CEO Astrana Health's is Brandon Sim, benoemd in Jan2024, heeft een ambtstermijn van minder dan een jaar. De totale jaarlijkse vergoeding van { bedraagt $ 14.31M, bestaande uit 5% salaris en 95% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 3.09% van de aandelen van het bedrijf, ter waarde $ 87.85M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 1.3 jaar en 5.8 jaar.
Belangrijke informatie
Brandon Sim
Algemeen directeur
US$14.3m
Totale compensatie
| Percentage CEO-salaris | 5.0% |
| Dienstverband CEO | less than a year |
| Eigendom CEO | 3.1% |
| Management gemiddelde ambtstermijn | 1.3yrs |
| Gemiddelde ambtstermijn bestuur | 5.8yrs |
Recente managementupdates
Recent updates
Astrana Health, Inc.'s (NASDAQ:ASTH) P/E Is Still On The Mark Following 25% Share Price Bounce
Oct 04
Is Astrana Health, Inc. (NASDAQ:ASTH) Trading At A 21% Discount?
Sep 26Astrana Health's (NASDAQ:ASTH) Returns On Capital Not Reflecting Well On The Business
Sep 12Is Astrana Health (NASDAQ:ASTH) Using Too Much Debt?
Aug 28Astrana Health, Inc.'s (NASDAQ:ASTH) 29% Jump Shows Its Popularity With Investors
Aug 02Is There Now An Opportunity In Astrana Health, Inc. (NASDAQ:ASTH)?
Jun 19Capital Allocation Trends At Astrana Health (NASDAQ:ASTH) Aren't Ideal
Jun 02Astrana Health, Inc. (NASDAQ:ASTH) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
May 09Investors Still Waiting For A Pull Back In Astrana Health, Inc. (NASDAQ:ASTH)
Apr 15At US$40.82, Is Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Worth Looking At Closely?
Feb 25Is Apollo Medical Holdings (NASDAQ:AMEH) Using Too Much Debt?
Feb 07Apollo Medical Holdings: Good Company, Not Quite A Hold
Jan 17With Apollo Medical Holdings, Inc. (NASDAQ:AMEH) It Looks Like You'll Get What You Pay For
Dec 27Returns On Capital At Apollo Medical Holdings (NASDAQ:AMEH) Have Stalled
Nov 08Should You Investigate Apollo Medical Holdings, Inc. (NASDAQ:AMEH) At US$30.62?
Oct 26Apollo Medical Holdings (NASDAQ:AMEH) Has A Pretty Healthy Balance Sheet
Sep 22Returns At Apollo Medical Holdings (NASDAQ:AMEH) Appear To Be Weighed Down
Aug 04A Look At The Intrinsic Value Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH)
Jul 19We Think Apollo Medical Holdings (NASDAQ:AMEH) Can Stay On Top Of Its Debt
Jun 19Apollo Medical Holdings' (NASDAQ:AMEH) Returns On Capital Are Heading Higher
May 05Does This Valuation Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Imply Investors Are Overpaying?
Apr 20Is Apollo Medical Holdings (NASDAQ:AMEH) A Risky Investment?
Mar 21Apollo Medical Holdings (NASDAQ:AMEH) Has More To Do To Multiply In Value Going Forward
Jan 06Is Apollo Medical Holdings (NASDAQ:AMEH) Using Too Much Debt?
Dec 16Apollo Medical to acquire Valley Oaks Medical Group
Oct 05Apollo Medical to acquire a San Francisco Bay area physicians' group, health plan
Sep 26A Look At The Fair Value Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH)
Sep 21The Return Trends At Apollo Medical Holdings (NASDAQ:AMEH) Look Promising
Sep 06With EPS Growth And More, Apollo Medical Holdings (NASDAQ:AMEH) Makes An Interesting Case
Aug 22Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | US$68m |
| Mar 31 2024 | n/a | n/a | US$62m |
| Dec 31 2023 | US$14m | US$712k | US$61m |
| Sep 30 2023 | n/a | n/a | US$45m |
| Jun 30 2023 | n/a | n/a | US$46m |
| Mar 31 2023 | n/a | n/a | US$45m |
| Dec 31 2022 | US$15m | US$670k | US$45m |
| Sep 30 2022 | n/a | n/a | US$58m |
| Jun 30 2022 | n/a | n/a | US$69m |
| Mar 31 2022 | n/a | n/a | US$70m |
| Dec 31 2021 | US$9m | US$364k | US$69m |
| Sep 30 2021 | n/a | n/a | US$70m |
| Jun 30 2021 | n/a | n/a | US$53m |
| Mar 31 2021 | n/a | n/a | US$47m |
| Dec 31 2020 | US$1m | US$124k | US$38m |
| Sep 30 2020 | n/a | n/a | US$35m |
| Jun 30 2020 | n/a | n/a | US$22m |
| Mar 31 2020 | n/a | n/a | US$18m |
| Dec 31 2019 | US$73k | US$24k | US$14m |
Compensatie versus markt: De totale vergoeding ($USD 14.31M ) Brandon } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 6.79M ).
Compensatie versus inkomsten: De vergoeding van Brandon is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.
CEO
Brandon Sim (30 yo)
less than a year
Tenure
US$14,311,250
Compensatie
Mr. Brandon K. Sim, MS, is President and Chief Executive Officer at Astrana Health, Inc. (formerly known as Apollo Medical Holdings, Inc.) since January 19, 2024 and had been its Co-Chief Executive Officer...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Co-Founder & Executive Chairman | 6.8yrs | US$5.22m | 2.4% $ 69.9m | |
| President & CEO | less than a year | US$14.31m | 3.09% $ 90.2m | |
| Co-Founder & Vice Chairman | less than a year | US$5.22m | 3.07% $ 89.6m | |
| CFO, COO & Corporate Secretary | 2.4yrs | US$5.70m | 0.31% $ 9.0m | |
| Senior Vice President of Health Affairs | less than a year | US$562.77k | 2.41% $ 70.5m | |
| Chief Accounting Officer | 2.3yrs | geen gegevens | 0.037% $ 1.1m | |
| Vice President of People & Operations | no data | geen gegevens | geen gegevens | |
| Chief Quality Officer | 3.6yrs | geen gegevens | geen gegevens | |
| President of Provider Solutions | 2.8yrs | geen gegevens | geen gegevens | |
| Chief Medical Officer for Texas | 1.3yrs | geen gegevens | geen gegevens | |
| Chief Medical Officer | less than a year | geen gegevens | 0.30% $ 8.9m | |
| Managing Director of the Capital Markets Group | less than a year | geen gegevens | geen gegevens |
1.3yrs
Gemiddelde duur
55yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van ASTH wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 1.3 jaar), wat duidt op een nieuw team.
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Co-Founder & Executive Chairman | 6.8yrs | US$5.22m | 2.4% $ 69.9m | |
| Co-Founder & Vice Chairman | less than a year | US$5.22m | 3.07% $ 89.6m | |
| Independent Director | 2.8yrs | US$211.95k | 0.015% $ 429.1k | |
| Lead Independent Director | 6.8yrs | US$374.01k | 0.036% $ 1.1m | |
| Independent Director | 11.4yrs | US$329.87k | 0.019% $ 554.1k | |
| Independent Director | 5.8yrs | US$273.71k | 0.032% $ 942.7k | |
| Director | 5.1yrs | US$274.13k | 0.017% $ 494.5k | |
| Director | 5.8yrs | US$211.95k | 0.16% $ 4.6m | |
| Independent Director | 2.8yrs | geen gegevens | geen gegevens |
5.8yrs
Gemiddelde duur
70yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van ASTH wordt beschouwd als ervaren (gemiddelde ambtstermijn 5.8 jaar).